3613 — Beijing Tong Ren Tang Chinese Medicine Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Market Cap
HK$7.70bn
Enterprise Value
HK$5.61bn
Revenue
HK$1.52bn

Annual income statement for Beijing Tong Ren Tang Chinese Medicine Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,433	1,315	1,556	1,731	1,525
Cost of Revenue
Gross Profit	1,013	953	1,120	1,150	1,047
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	781	646	778	920	901
Operating Profit	652	669	778	812	624
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	689	686	778	826	688
Provision for Income Taxes
Net Income After Taxes	577	568	652	691	591
Minority Interest
Net Income Before Extraordinary Items
Net Income	556	542	608	646	540
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	556	542	608	646	540
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.666	0.647	0.726	0.771	0.668
Dividends per Share
Special Dividends per Share